• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. GRAFTMASTER; CORONARY COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. GRAFTMASTER; CORONARY COVERED STENT Back to Search Results
Model Number 1012581-19
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 05/12/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to treat a perforation in the distal right coronary artery (rca).The 3.5x19 mm graftmaster covered stent was implanted at 12 atmospheres and sealed the perforation; however, a clot burden was noted.A manual thrombectomy catheter was used to open the stent from the clot burden.A 4.0x16 mm graftmaster covered stent was implanted at 12 atmospheres and sealed the perforation.The 4.0x16 mm graftmaster covered stent did not cause or contribute to adverse events or complications.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.The reported patient effect of thrombosis is listed in the graftmaster rx coronary stent graft systems instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTMASTER
Common Device Name
CORONARY COVERED STENT
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary UNK
EI   UNK
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key22118418
Report Number2024168-2025-05547
Device Sequence Number14515911
Product Code NIV
UDI-Device Identifier08717648176401
UDI-Public(01)08717648176401(17)250930(10)3102641
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
H000001
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Model Number1012581-19
Device Catalogue Number1012581-19
Device Lot Number3102641
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/13/2025
Supplement Date Received by Manufacturer06/09/2025
Initial Report FDA Received Date05/30/2025
Supplement Report FDA Received Date06/23/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
Patient SexMale
-
-